PRINT
Home
Contact Us
Site Map
Mike Paulden
Mike Paulden, MSc, MA (Cantab.), is a Research Associate at THETA. He was previously a Research Fellow in the Team for Economic Evaluation and Health Technology Assessment at the Centre for Health Economics, University of York. He holds an MA in Economics from the University of Cambridge and an MSc in Health Economics from the University of York.
Mike's interests are in the economic evaluation of health care technologies. He has worked on Health Technology Assessment (HTA) projects for the National Institute for Health Research (NIHR) and the National Institute for Health and Clinical Excellence (NICE) in the UK, and for the Medical Advisory Secretariat (MAS) of the Ministry of Health and Long-Term Care (MOHLTC) in Ontario. He has contributed to models evaluating the cost-effectiveness of a variety of health technologies and interventions, including formal screening programs for post-natal depression, neuromise inhibitors for the treatment of influenza and non-invasive imaging for the diagnosis of coronary artery disease.
Mike's theoretical work has focused on a number of issues which carry implications for social decision making in health care, including the perspective on social choice adopted by decision makers, the cause and effect of future growth in the cost-effectiveness threshold and the rate of time preference for health implied by health sector budget allocations. This work has addressed a long-running dispute over the use of differential discounting in cost-effectiveness analysis and has challenged current discounting practice in the UK and elsewhere.
Mike's contact details are available at mikepaulden.tel.
Publications
NIHR Health Technology Assessments
Antiviral drugs for the treatment of influenza
Burch J, Paulden M, Conti S, Stock C, Corbett M, Welton N, et al. Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation. Health Technol Assess 2009;13(58).
URL: http://www.hta.ac.uk/1701
PDF: http://www.hta.ac.uk/fullmono/mon1701.pdf
NICE guidance: http://guidance.nice.org.uk/TA168
Methods to identify postnatal depression in primary care
Hewitt C E, Gilbody S M, Brealey S, Paulden M, Palmer S, Mann R, et al. Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis. Health Technol Assess 2009;13(36).
URL: http://www.hta.ac.uk/1521
PDF: http://www.hta.ac.uk/fullmono/mon1336.pdf
Paulden M, Palmer S, Hewitt C E, Gilbody S M. Screening for postnatal depression in primary care: cost effectiveness analysis. BMJ 2009;339:b5203.
PDF: http://www.bmj.com/cgi/reprint/339/dec22_1/b5203
PDF (print version ) http://www.bmj.com/cgi/section_pdf/339/dec22_1/b5203.pdf
URL: http://www.bmj.com/cgi/content/abstract/339/dec22_1/b5203
Sugammadex for the reversal of muscle relaxation in general anaesthesia
Chambers D, Paulden M, Paton F, Heirs M, Duffy S, Craig D, et al. Sugammadex for the reversal of muscle relaxation in general anaesthesia: systematic review and economic assessment. Health Technol Assess 2010;14(00).
URL: http://www.hta.ac.uk/1780
PDF (available May 2010): http://www.hta.ac.uk/fullmono/mon1780.pdf
NICE Single Technology Appraisals
Alitretinoin for Severe Chronic Hand Eczema
Rodgers M, Griffin S, Paulden M, Slack R, Duffy S, Ingram J R, Woolacott N, Sculpher M. Alitretinoin for Severe Chronic Hand Eczema: A NICE Single Technology Appraisal. PharmacoEconomics 2010;28(5):351-62.
URL: http://adisonline.com/pharmacoeconomics/Fulltext/2010/28050/Alitretinoin_for_Severe_Chronic_Hand_Eczema__A.2.aspx
Theoretical papers
Discounting and decision making
Claxton K, Paulden M, Gravelle H, Brouwer W, Culyer A J. Discounting and decision making in the economic evaluation of health-care technologies. Health Economics 2010
URL: http://www3.interscience.wiley.com/journal/123421690/abstract
Paulden M, Claxton K. Budget allocation and the revealed social rate of time preference for health. CHE Research Paper 53. October 2009.
URL: http://www.york.ac.uk/inst/che/pdf/rp53.pdf
Both papers above were presented at CADTH in April 2010
Poster: http://theta.utoronto.ca/presentations/theta_cadth_2010_paulden.pdf
Paulden, M. Some problems with the UK Treasury's discount rate. THETA Working Paper 2. March 2010.
URL: http://theta.utoronto.ca/papers/THETA_Working_Paper_2.pdf
Does CEA discriminate against patients with short life expectancy?
Paulden M, Culyer A J. Does cost-effectiveness analysis discriminate against patients with short life expectancy? Matters of logic and matters of context. THETA Working Paper 1. March 2010.
URL: http://theta.utoronto.ca/papers/THETA_Working_Paper_1.pdf
The paper above was presented at SMDM Europe (oral) and HTAi (poster click here to download) in June 2010.
Email Address: mike.paulden@theta.utoronto.ca